Zyngenia, Inc Email Format

BiotechnologyMaryland, United States11-50 Employees

Zyngenia, Inc. is a biotechnology research company focused on creating a new class of biotherapeutics that address disease complexity by simultaneously targeting multiple physiological pathways. Its approach centers on monoclonal antibody–based drugs engineered to engage several validated disease targets through added peptide binding motifs, enabling multi-target activity within a single molecule. These agents aim to treat multifactorial conditions such as cancer, inflammation, and autoimmune disorders while preserving the drug-like properties and conventional production methods of antibodies.
The company has advanced three programs into preclinical development and has demonstrated preclinical proof-of-concept for bi-specific and tri-specific constructs in cancer and inflammation. Zyngenia is based in Gaithersburg, Maryland, and operates in the biotechnology research sector.

Sign up for free to view info

Company overview Employee directory